Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Chinese clinical oncology"
DOI: 10.21037/cco.2017.06.04
Abstract: The complex interaction between the immune system, the tumor and the microenvironment in pancreatic ductal adenocarcinoma (PDA) leads to the resistance of PDA to immunotherapy. To overcome this resistance, combination immunotherapy is being proposed. However,… read more here.
Keywords: combinations immunotherapy; rational combinations; immunotherapy pancreatic; pancreatic ductal ... See more keywords